Hazard Information | Back Directory | [Uses]
Relfovetmab is an anti-NGF monoclonal antibody (mAb)[1]. | [IC 50]
NGF | [References]
[1] Liu Wenshe Ray, et al. Protease switch for dual targets chimeric antigen receptor T-cell therapy. Patent. WO2021087245. |
|
Company Name: |
Biolab Reagents
|
Tel: |
18108604356 18108604356 |
Website: |
www.biolabreagent.com/ |
Company Name: |
Cell Sciences
|
Tel: |
9785721070 |
Website: |
www.cellsciences.com |
|